Document Detail

Haemochromatosis gene mutations and risk of coronary heart disease: a west of Scotland coronary prevention study (WOSCOPS) substudy.
MedLine Citation:
PMID:  14966054     Owner:  NLM     Status:  MEDLINE    
OBJECTIVES: To measure the frequency of genotypes of the HFE (haemochromatosis) gene in patients recruited to the west of Scotland coronary prevention study (WOSCOPS), and relate them to the subsequent occurrence of coronary clinical events.
DESIGN: Nested case-control study, drawing samples of DNA from the biological bank of a cohort study.
PATIENTS: Men aged 45-64 years in 1989, with moderate hypercholesterolaemia and no evidence of coronary heart disease at baseline.
INTERVENTIONS: Follow up for a mean period of 4.9 years. Typing for C282Y and H63D mutations of the HFE gene in 482 subjects with a subsequent coronary event and 1104 without an event.
RESULTS: The C282Y mutation was present in 81 of 482 cases (16.8%) and 182 of 1104 controls (16.5%). Comparing the prevalence of gene mutations in the cases and controls, there were no significant differences. The hazard ratio for C282Y heterozygotes was 1.03 (95% confidence interval (CI) 0.77 to 1.36) and for C282Y/H63D compound heterozygotes 1.04 (95% CI 0.50 to 2.14). Prespecified subgroup analyses of the pravastatin, placebo, smoking, and non-smoking groups showed no significant differences between cases and controls. Repeating the analyses after adjusting for possible confounding factors produced no change in the results.
CONCLUSIONS: In a population of moderately hypercholesterolaemic middle aged Scottish men who did not have any evidence of coronary heart disease at baseline, the presence of a C282Y mutation in the HFE gene did not predict the occurrence of coronary events over a mean follow up of 4.9 years.
I R Gunn; F K Maxwell; D Gaffney; A D McMahon; C J Packard
Related Documents :
18243394 - Association of the glu298asp polymorphism of the enos gene with ischemic heart disease ...
12629034 - History of hypertension and enhanced thrombogenic activity in postinfarction patients.
3337484 - Myocardial infarct extension: occurrence, outcome, and risk factors in the multicenter ...
6375364 - Decline in coronary heart disease mortality. old questions and new facts.
6610394 - Clinical, hemodynamic, and operative descriptors affecting outcome of aortic valve repl...
16837634 - Anemia as a predictor of cardiovascular events in patients with elevated serum creatinine.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Heart (British Cardiac Society)     Volume:  90     ISSN:  1468-201X     ISO Abbreviation:  Heart     Publication Date:  2004 Mar 
Date Detail:
Created Date:  2004-02-17     Completed Date:  2004-03-16     Revised Date:  2013-06-09    
Medline Journal Info:
Nlm Unique ID:  9602087     Medline TA:  Heart     Country:  England    
Other Details:
Languages:  eng     Pagination:  304-6     Citation Subset:  AIM; IM    
Department of Biochemistry, Wishaw General Hospital, Wishaw, Strathclyde, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Case-Control Studies
Coronary Disease / epidemiology,  genetics*,  prevention & control
Follow-Up Studies
Gene Frequency
Histocompatibility Antigens Class I / genetics*
Hypercholesterolemia / complications,  epidemiology
Membrane Proteins / genetics*
Middle Aged
Mutation / genetics*
Risk Factors
Scotland / epidemiology
Reg. No./Substance:
0/HFE protein, human; 0/Histocompatibility Antigens Class I; 0/Membrane Proteins

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Diagnostic and prognostic evaluation of left ventricular systolic heart failure by plasma N-terminal...
Next Document:  Long term outcome up to 30 years after the Mustard or Senning operation: a nationwide multicentre st...